1. Home
  2. ZVRA vs FTW Comparison

ZVRA vs FTW Comparison

Compare ZVRA & FTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVRA
  • FTW
  • Stock Information
  • Founded
  • ZVRA 2006
  • FTW N/A
  • Country
  • ZVRA United States
  • FTW
  • Employees
  • ZVRA N/A
  • FTW N/A
  • Industry
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • FTW Oil & Gas Production
  • Sector
  • ZVRA Health Care
  • FTW Energy
  • Exchange
  • ZVRA Nasdaq
  • FTW Nasdaq
  • Market Cap
  • ZVRA 467.6M
  • FTW 465.8M
  • IPO Year
  • ZVRA 2015
  • FTW 2024
  • Fundamental
  • Price
  • ZVRA $8.99
  • FTW $10.45
  • Analyst Decision
  • ZVRA Strong Buy
  • FTW
  • Analyst Count
  • ZVRA 7
  • FTW 0
  • Target Price
  • ZVRA $21.71
  • FTW N/A
  • AVG Volume (30 Days)
  • ZVRA 1.5M
  • FTW N/A
  • Earning Date
  • ZVRA 11-05-2025
  • FTW N/A
  • Dividend Yield
  • ZVRA N/A
  • FTW N/A
  • EPS Growth
  • ZVRA N/A
  • FTW N/A
  • EPS
  • ZVRA 0.54
  • FTW N/A
  • Revenue
  • ZVRA $84,388,000.00
  • FTW N/A
  • Revenue This Year
  • ZVRA $336.43
  • FTW N/A
  • Revenue Next Year
  • ZVRA $54.26
  • FTW N/A
  • P/E Ratio
  • ZVRA $16.52
  • FTW N/A
  • Revenue Growth
  • ZVRA 244.60
  • FTW N/A
  • 52 Week Low
  • ZVRA $6.19
  • FTW N/A
  • 52 Week High
  • ZVRA $13.16
  • FTW N/A
  • Technical
  • Relative Strength Index (RSI)
  • ZVRA 38.60
  • FTW N/A
  • Support Level
  • ZVRA $8.51
  • FTW N/A
  • Resistance Level
  • ZVRA $9.69
  • FTW N/A
  • Average True Range (ATR)
  • ZVRA 0.58
  • FTW 0.00
  • MACD
  • ZVRA -0.15
  • FTW 0.00
  • Stochastic Oscillator
  • ZVRA 15.26
  • FTW 0.00

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Share on Social Networks: